aplastic anemia | Page 37 | Aplastic Anemia & MDS International Foundation

aplastic anemia

A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

Author(s): 
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y
Primary Author: 
Ashizawa M
Journal Title: 
Int J Hematol
Original Publication Date: 
Feb 2014

Conditioning regimens consisting of reduced-dose

Bone Marrow Diseases: 

Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia

Author(s): 
Scheinberg P, Townsley D, Dumitriu B, Scheinberg P, Weinstein B, Rios O, Wu CO, Young NS
Primary Author: 
Scheinberg P
Journal Title: 
Am J Hematol
Original Publication Date: 
Jan 2014

The effectiveness of salvage therapy for

Bone Marrow Diseases: 

Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia

Author(s): 
Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz S, Teigler-Schlegel A, Walther JU, Schlegelberger B, Göhring G, Nöllke P, Führer M, Niemeyer CM
Primary Author: 
Yoshimi A
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Dec 2013

Secondary myelodysplastic syndrome and

Bone Marrow Diseases: 

Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities

Author(s): 
Socié G
Primary Author: 
Socié G
Journal Title: 
Hematology Am Soc Hematol Educ Program
Original Publication Date: 
Dec 2013

Allogeneic BM transplantation from an HLA-identical sibling donor leads to long-term survival in the majority of patients (> 80%). Therefore, survival is no longer the sole concern and attention has to be paid to decreasing the incidence and severity of long-term complications.

Bone Marrow Diseases: 

Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug

Author(s): 
Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE
Primary Author: 
Desmond R
Journal Title: 
Blood
Original Publication Date: 
Dec 2013

About a quarter of patients with severe

Bone Marrow Diseases: 

Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

Author(s): 
Williams DA, Bennett C, Bertuch A, Bessler M, Coates T, Corey S, Dror Y, Huang J, Lipton J, Olson TS, Reiss UM, Rogers ZR, Sieff C, Vlachos A, Walkovich K, Wang W, Shimamura A
Primary Author: 
Williams DA
Journal Title: 
Pediatr Blood Cancer
Original Publication Date: 
Nov 2013

BACKGROUND:

Bone Marrow Diseases: